Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Impact of HIV infection, highly active antiretroviral therapy, and hepatitis C coinfection on serum interleukin-27.

Guzzo C, Hopman WM, Che Mat NF, Wobeser W, Gee K.

AIDS. 2010 Jun 1;24(9):1371-4. doi: 10.1097/QAD.0b013e3283391d2b.

PMID:
20375875
[PubMed - indexed for MEDLINE]
2.

Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.

Macías J, Pineda JA, Lozano F, Corzo JE, Ramos A, León E, García-García JA, Fernández-Rivera J, Mira JA, Gómez-Mateos J.

Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):675-80. Epub 2003 Oct 23.

PMID:
14574616
[PubMed - indexed for MEDLINE]
3.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
[PubMed - indexed for MEDLINE]
4.

Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.

Schulze Zur Wiesch J, Pieper D, Stahmer I, Eiermann T, Buggisch P, Lohse A, Hauber J, van Lunzen J.

Clin Infect Dis. 2009 Aug 1;49(3):466-72. doi: 10.1086/600399.

PMID:
19580412
[PubMed - indexed for MEDLINE]
Free Article
5.

Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment.

de Larrañaga GF, Wingeyer SD, Puga LM, Alonso BS, Benetucci JA.

Eur J Clin Microbiol Infect Dis. 2006 Feb;25(2):98-103.

PMID:
16477441
[PubMed - indexed for MEDLINE]
6.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
[PubMed - indexed for MEDLINE]
7.

Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.

Lalezari JP, Beal JA, Ruane PJ, Cohen CJ, Jacobson EL, Sundin D, Leong WP, Raffanti SP, Wheeler DA, Anderson RD, Keiser P, Schrader SR, Goodgame JC, Steinhart CR, Murphy RL, Wolin MJ, Smith KA.

HIV Clin Trials. 2000 Nov-Dec;1(3):1-15.

PMID:
11590500
[PubMed - indexed for MEDLINE]
8.

Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.

Beq S, Delfraissy JF, Theze J.

Eur Cytokine Netw. 2004 Oct-Dec;15(4):279-89. Review.

PMID:
15627636
[PubMed - indexed for MEDLINE]
9.

Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.

Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y.

Blood. 2000 Dec 15;96(13):4293-9.

PMID:
11110704
[PubMed - indexed for MEDLINE]
Free Article
10.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
[PubMed - indexed for MEDLINE]
11.

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.

Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, Nielsen H, Moller A, Sorensen HT, Obel N.

Clin Infect Dis. 2006 May 15;42(10):1481-7. Epub 2006 Apr 12.

PMID:
16619163
[PubMed - indexed for MEDLINE]
Free Article
12.

Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.

Jansen CA, De Cuyper IM, Steingrover R, Jurriaans S, Sankatsing SU, Prins JM, Lange JM, van Baarle D, Miedema F.

AIDS. 2005 Jul 22;19(11):1145-54.

PMID:
15990567
[PubMed - indexed for MEDLINE]
13.

Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.

Beilke MA, Traina-Dorge VL, Sirois M, Bhuiyan A, Murphy EL, Walls JM, Fagan R, Winsor EL, Kissinger PJ.

Clin Infect Dis. 2007 May 1;44(9):1229-34. Epub 2007 Mar 19.

PMID:
17407044
[PubMed - indexed for MEDLINE]
Free Article
14.

IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy.

Orsilles MA, Pieri E, Cooke P, Caula C.

APMIS. 2006 Jan;114(1):55-60.

PMID:
16499662
[PubMed - indexed for MEDLINE]
15.

Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.

Castagna A, Galli L, Torti C, D'Arminio Monforte A, Mussini C, Antinori A, Cozzi-Lepri A, Ladisa N, De Luca A, Seminari E, Gianotti N, Lazzarin A.

Antivir Ther. 2010;15(2):165-75. doi: 10.3851/IMP1513.

PMID:
20386071
[PubMed - indexed for MEDLINE]
16.

Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.

Caudai C, Pianese M, Zacchini F, Toti M, Zazzi M, Valensin PE.

J Clin Virol. 2005 Feb;32(2):151-5.

PMID:
15653418
[PubMed - indexed for MEDLINE]
17.

Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.

Benito JM, López M, Lozano S, González-Lahoz J, Soriano V.

J Infect Dis. 2008 Nov 15;198(10):1466-73. doi: 10.1086/592716.

PMID:
18847371
[PubMed - indexed for MEDLINE]
Free Article
18.

Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease.

Santin M, Mestre M, Shaw E, Barbera MJ, Casanova A, Niubo J, Bolao F, Podzamczer D, Gudiol F.

Eur J Clin Microbiol Infect Dis. 2008 Jan;27(1):65-73.

PMID:
17938979
[PubMed - indexed for MEDLINE]
19.

Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.

Kapogiannis BG, Henderson SL, Nigam P, Sharma S, Chennareddi L, Herndon JG, Robinson HL, Amara RR.

AIDS Res Hum Retroviruses. 2006 Mar;22(3):272-82.

PMID:
16545014
[PubMed - indexed for MEDLINE]
20.

Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART.

Martinez-Mariño B, Shiboski S, Hecht FM, Kahn JO, Levy JA.

AIDS. 2004 Oct 21;18(15):1991-9.

PMID:
15577620
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk